ANIK

ANIKA THERAPEUTICS INC

ANIK·035255108·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-Activist

ANIK (ANIKA THERAPEUTICS INC) is held by 83 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($23.1M), MORGAN STANLEY ($12.6M), VANGUARD CAPITAL MANAGEMENT LLC ($8.8M). Net institutional sentiment: Mixed.

83
Holders
Avg rating(23 Elite)
$127.3M
Total Value
60% (89)
Fund Consensus
49 buying - 33 selling
ANIKSmart Money Verdict
View all
Held by 83 funds
23 elite
Who's Trading
InsiderHIHENNEMAN JOHN B IIIBuy $73KMay 1, 2026
InsiderGDGriffin Stephen D.Buy $150KApr 30, 2026
ActivistVAVanguard Capital Management5.2%Apr 29, 2026
ActivistThe Vanguard GroupThe Vanguard Group0.0%Mar 26, 2026
ActivistCACaligan Partners LP9.9%Jan 27, 2026
ActivistTITrigran Investments, Inc.1.2%Jan 8, 2026
ActivistBPBlackRock Portfolio Management LLC5.5%Oct 17, 2025
ActivistBlackRock, Inc.BlackRock, Inc.6.8%Apr 17, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
1.6M(-3.6%)$23.1M0.0%+1.63%
0
Increased
872,066(+12.9%)$12.6M0.0%+30.74%
32
New
605,777$8.8M0.0%+8.33%
38
Decreased
502,217(-2.6%)$7.3M0.0%-62.51%
0
Decreased
458,847(-7.2%)$6.7M0.0%-43.60%
0
Increased
353,174(+334.5%)$5.1M0.0%-4.32%
44
Increased
346,092(+2.8%)$5M0.0%-27.61%
28
Increased
330,051(+1.4%)$4.8M0.0%-48.73%
27
Increased
272,269(+293.0%)$3.9M0.0%+14.96%
43
Increased
265,627(+35.8%)$3.9M0.0%+15.22%
35
Increased
236,120(+1.0%)$3.4M0.0%+64.93%
27
Decreased
229,796(-22.9%)$3.3M0.0%-8.39%
0
Increased
217,878(+32.1%)$3.2M0.0%+36.21%
34
Increased
137,584(+37.1%)$2M0.0%+10.31%
34
Increased
133,074(+366.2%)$1.9M0.0%+12.75%
42
Increased
125,826(+23.9%)$1.8M0.0%+49.06%
31
Increased
124,293(+93.4%)$1.8M0.0%+29.85%
41
Increased
120,717(+126.9%)$1.8M0.0%+14.19%
42
Increased
114,399(+7.6%)$1.7M0.0%-48.54%
28
Increased
111,836(+0.1%)$1.6M0.0%-51.15%
26

Showing 1-20 of 89

1 / 5

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used